Antigen-driven interactions with dendritic cells and expansion of Foxp3+ regulatory T cells occur in the absence of inflammatory signals

被引:10
作者
Chappert, Pascal [1 ]
Leboeuf, Marylne [1 ]
Rameau, Philippe [1 ]
Stockholm, Daniel [1 ]
Liblau, Roland [2 ]
Danos, Olivier [1 ,3 ]
Davoust, Jean M. [1 ,4 ]
Gross, David-Alexandre [1 ]
机构
[1] CNRS, FRE3018, UMR 8115, F-91002 Evry, France
[2] Univ Toulouse 3, Inst Natl Sante Rech Med, U563, F-31062 Toulouse, France
[3] Univ Paris 05, Inst Natl Sante Rech Med U781, Paris, France
[4] Hop Necker Enfants Malad, Inst Natl Sante & Rech Med U580, Paris, France
关键词
D O I
10.4049/jimmunol.180.1.327
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Foxp3(+) regulatory T cells (Tregs) play a pivotal role in the maintenance of peripheral T cell tolerance and are thought to interact with dendritic cells (DC) in secondary lymphoid organs. We analyzed here the in vivo requirements for selective expansion of Ag-specific Treg vs CD4(+)CD25(-) effector T cells and engagement of Ag-specific Treg-DC interactions in secondary lymphoid organs. Using i.v. Ag delivery in the absence of inflammation, we found that CD4(+)CD25(+)Foxp3(+) Tregs undergo vigorous expansion and accumulate whereas naive CD4(+)CD25(-)Foxp3(-) T cells undergo abortive activation. Quantifying directly the interactions between Tregs and CD11c(+) DC, we found that Tregs establish cognate contacts with endogenous CD11c(+) DC in spleen and lymph nodes at an early time point preceding their expansion. Importantly, we observed that as few as 10(3) Tregs selectively expanded by i.v. Ag injection are able to suppress B and T cell immune responses in mouse recipients challenged with the Ag. Our results demonstrate that Tregs are selectively mobilized by Ag recognition in the absence of inflammatory signals, and can induce thereafter potent tolerance to defined Ag targets.
引用
收藏
页码:327 / 334
页数:8
相关论文
共 49 条
[1]   Peptide-based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities [J].
Anderton, SM .
IMMUNOLOGY, 2001, 104 (04) :367-376
[2]   In vivo instruction of suppressor commitment in naive T cells [J].
Apostolou, I ;
von Boehmer, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (10) :1401-1408
[3]   Origin of regulatory T cells with known specificity for antigen [J].
Apostolou, I ;
Sarukhan, A ;
Klein, L ;
von Boehmer, H .
NATURE IMMUNOLOGY, 2002, 3 (08) :756-763
[4]  
Bercovici N, 1999, EUR J IMMUNOL, V29, P345, DOI 10.1002/(SICI)1521-4141(199901)29:01<345::AID-IMMU345>3.0.CO
[5]  
2-K
[6]   Cutting edge:: Self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells [J].
Cozzo, C ;
Larkin, J ;
Caton, AJ .
JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :5678-5682
[7]   T-CELL DELETION IN HIGH ANTIGEN DOSE THERAPY OF AUTOIMMUNE ENCEPHALOMYELITIS [J].
CRITCHFIELD, JM ;
RACKE, MK ;
ZUNIGAPFLUCKER, JC ;
CANNELLA, B ;
RAINE, CS ;
GOVERMAN, J ;
LENARDO, MJ .
SCIENCE, 1994, 263 (5150) :1139-1143
[8]   Multicolour analysis and local image correlation in confocal microscopy [J].
Demandolx, D ;
Davoust, J .
JOURNAL OF MICROSCOPY, 1997, 185 :21-36
[9]   Therapeutic potential of self-antigen-specific CD4+CD25+ regulatory T cells selected in vitro from a polyclonal repertoire [J].
Fisson, S ;
Dielti, F ;
Trenado, A ;
Billiard, F ;
Liblau, R ;
Klatzmann, D ;
Cohen, JL ;
Salomon, BL .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (04) :817-827
[10]   Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state [J].
Fisson, S ;
Darrasse-Jèze, G ;
Litvinova, E ;
Septier, F ;
Klatzmann, D ;
Liblau, R ;
Salomon, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (05) :737-746